Tiffany, Kors to Re...
Health Care: Drugs
Celgene Corporation (CELG: NASDAQ)
$122.58 -1.06 | -0.86%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:02/27/06
Price Earnings Ratio:37.58
Price Earnings Comparisons:
| CELG | Sector Avg. | S&P 500 |
|---|---|---|
| 37.58 | 37.60 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 21.63 | 77.45 | 120.20 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 13.70 | 1.05 | 0.27 |
| Net Income | 10.50 | 0.87 | 0.23 |
| EPS | 15.80 | 1.00 | 0.26 |
Earnings for CELG:
| EBITDA | 2.20B |
| REVENUE | 5.51B |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.31 | $1.29 | $5.34 | $6.50 |
| Number of Analysts | 4 | 4 | 4 | 4 |
| High Estimate | $1.36 | $1.37 | $5.59 | $7.09 |
| Low Estimate | $1.25 | $1.26 | $5.14 | $6.15 |
| Prior Year | $1.12 | $1.19 | $4.50 | $5.34 |
| Growth Rate (Year over Year) | 16.74% | 8.61% | 18.61% | 21.73% |
Portfolios with CELG
- Portfolio NameUser Type
- UserQuicksilver55
- Userdennis all star
- Userportfolio 1.1
- UserCraigMcIlquham
- User4 Overvalued Biotechs
- ProRay Dalio - Bridgewater Ass...
- ProBill Miller - Legg Mason Ca...
- ContributorStocks Rising On Unusual Vo...
- UserTest Portfolio
- UserMike Fatah's Mega Stock Por...
Latest CELG Headlines from TheStreet
- Celgene Corporation (CELG): Today's Featured Health Care Laggard 04.18.13 | 05:04 pm
- The Next Big Thing In Biotech: Large-Cap Earnings
04.18.13 | 09:04 am - 5 Stocks Pushing The Drugs Industry Downward 04.15.13 | 01:04 pm
- Cramer's 6 Stocks in 60 Seconds: UA ADBE FTNT ACAD CELG RLGY (Update 1) 04.11.13 | 05:04 pm
- Health Care Standout Celgene Corporation (CELG) Making Gains Today 04.11.13 | 05:04 pm
- Celgene Corporation Stock Buy Recommendation Reiterated (CELG) 04.11.13 | 10:04 am
- Celgene Reaches New 52-Week High (CELG) 04.10.13 | 11:04 am
- Market Takes Aim at Historic Highs Once Again 04.10.13 | 09:04 am
- Risk Of A Major Stock Correction Is Growing 04.09.13 | 01:04 pm
- Biotech Multiples Are Soaring But M&A Is Dead 04.08.13 | 12:04 pm
Press Releases for CELG
- Celgene Corporation To Webcast At Two Upcoming Investor Conferences And The American Academy Of Dermatology Annual Meeting - Business Wire 02.28.13 | 08:02 am
- Celgene Announces $600 Million Accelerated Share Repurchase Program - Business Wire 02.20.13 | 08:02 am
- Celgene Provides REVLIMID® Regulatory Update - Business Wire 02.11.13 | 07:02 am
- POMALYST(R) Brand Therapy (Photo: Business Wire) - Business Wire 02.08.13 | 03:02 pm
- Celgene Corporation To Webcast At Upcoming Investor Conferences - Business Wire 02.04.13 | 08:02 am
- Celgene Reports Strong Fourth Quarter And Full Year 2012 Operating And Financial Results - Business Wire 01.24.13 | 07:01 am
- The True Effect: Positive Findings - Research Report On Celgene Corporation And Gilead Sciences, Inc. - PR Newswire 01.23.13 | 08:01 am
- ABRAXANE® Plus Gemcitabine Demonstrates Significant Survival Advantage In Phase III Study Of Patients With Advanced Pancreatic Cancer - Business Wire 01.22.13 | 06:01 pm
- Celgene Corporation Announces Financial Outlook And Preliminary 2012 Results - Business Wire 01.07.13 | 11:01 am
- Celgene Corporation To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 12.21.12 | 08:12 am
Partner Headlines for CELG
- Alkermes Leaps On Study Results, May Offer New Entry - Investor's Business Daily 04.17.13 | 05:04 pm
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Stocks On The Move Table Identifies Emerging Leaders - Investor's Business Daily 04.10.13 | 05:04 pm
- How The IBD 50 Can Help Investors Find Winning Stocks - Investor's Business Daily 04.05.13 | 04:04 pm
- Stocks Open Sharply Lower After Employment Report - Investor's Business Daily 04.05.13 | 10:04 am
- Benzinga's Top Upgrades - Benzinga 04.05.13 | 08:04 am
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Top Funds' New Buys: Lumber Liquidators, Celgene - Investor's Business Daily 04.02.13 | 06:04 pm
- U.S. Mutual Funds Up 10% In Q1; Managers' Top Buys - Investor's Business Daily 04.02.13 | 06:04 pm
